These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. N-truncated Aβ Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359 [TBL] [Abstract][Full Text] [Related]
5. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry. Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712 [TBL] [Abstract][Full Text] [Related]
6. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
8. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain. Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of heparanase lowers the amyloid burden in amyloid-β precursor protein transgenic mice. Jendresen CB; Cui H; Zhang X; Vlodavsky I; Nilsson LNG; Li JP J Biol Chem; 2015 Feb; 290(8):5053-5064. PubMed ID: 25548284 [TBL] [Abstract][Full Text] [Related]
10. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease. Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867 [TBL] [Abstract][Full Text] [Related]
11. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease. Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705 [TBL] [Abstract][Full Text] [Related]
12. Amyloid precursor protein transgenic mouse models and Alzheimer's disease: understanding the paradigms, limitations, and contributions. Kokjohn TA; Roher AE Alzheimers Dement; 2009 Jul; 5(4):340-7. PubMed ID: 19560104 [TBL] [Abstract][Full Text] [Related]
13. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease. Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835 [TBL] [Abstract][Full Text] [Related]
14. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model. Baik SH; Kang S; Son SM; Mook-Jung I Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617 [TBL] [Abstract][Full Text] [Related]
15. Serum β-amyloid peptide levels spike in the early stage of Alzheimer-like plaque pathology in an APP/PS1 double transgenic mouse model. He J; Qiao JP; Zhu S; Xue M; Chen W; Wang X; Tempier A; Huang Q; Kong J; Li XM Curr Alzheimer Res; 2013 Nov; 10(9):979-86. PubMed ID: 24117120 [TBL] [Abstract][Full Text] [Related]
16. Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer's disease and transgenic mouse models. Reinert J; Richard BC; Klafki HW; Friedrich B; Bayer TA; Wiltfang J; Kovacs GG; Ingelsson M; Lannfelt L; Paetau A; Bergquist J; Wirths O Acta Neuropathol Commun; 2016 Mar; 4():24. PubMed ID: 26955942 [TBL] [Abstract][Full Text] [Related]